Trials / Withdrawn
WithdrawnNCT03451708
OKS for the Treatment of Hemispatial Neglect
Optokinetic Stimulation for the Treatment of Hemispatial Neglect - Safety and Efficacy Studies
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Hemispatial neglect is a disorder where the patient has difficulty attending to objects and information in the left side of space, which occurs following strokes to the right side of the brain. This project is designed to help us understand how optokinetic stimulation treats the symptoms of hemispatial neglect.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OKS | Optokinetic stimulation will be displayed on a see-through liquid crystal display lens placed in front of the subjects. |
Timeline
- Start date
- 2018-05-01
- Primary completion
- 2023-03-31
- Completion
- 2023-03-31
- First posted
- 2018-03-02
- Last updated
- 2024-06-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03451708. Inclusion in this directory is not an endorsement.